Delgado-Ureņa, Mayte <br/><br/>
Circulating tumor cells criteria (CyCAR) versus standard RECIST criteria for treatment response assessment in metastatic colorectal cancer patients.  [electronic resource] 

 -  Journal of translational medicine  09 2018 
 - 251 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1479-5876 
<br/><br/><label>Standard No.: </label>10.1186/s12967-018-1624-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Cell Line, Tumor<br/>Colorectal Neoplasms--drug therapy<br/>Female<br/>Fluorouracil--therapeutic use<br/>Follow-Up Studies<br/>Humans<br/>Leucovorin--therapeutic use<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Neoplasm Metastasis<br/>Neoplastic Cells, Circulating--pathology<br/>Organoplatinum Compounds--therapeutic use<br/>Prognosis<br/>Proportional Hazards Models<br/>Receptors, Vascular Endothelial Growth Factor--metabolism<br/>Reference Standards<br/>Response Evaluation Criteria in Solid Tumors<br/>Treatment Outcome